Background illustration for clinical trials search

Paid Clinical Trials Maryland

Discover 2,427 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,427

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

for

Viral Infection, Primary Immune Deficiency Disorder

Location: Vallhala NY, Philadelphia PA, Baltimore MD, Columbus OH,

Sponsor: New York Medical College

Sex: All

Age: 0 - 70+

Code: NCT04197596

Phase1, Phase2, Recruiting

Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene

for

Genotype, Retinal Disease

Location: Bethesda MD

Sponsor: National Eye Institute (NEI)

Sex: All

Age: 18 - 70+

Code: NCT01145196

Recruiting

Virtual Reality Therapy for Cancer-Treatment Associated Symptoms

for

Cancer, Cancer Pain, Virtual Reality

Location: Baltimore MD

Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18 - 70+

Code: NCT06248216

Recruiting

Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT

for

Diabetic Macular Edema

Location: Norfolk VA, Baltimore MD, Fairfax VA

Sponsor: Notal Vision Inc.

Sex: All

Age: 0+

Code: NCT05745116

Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for

Breast Cancer

Location: Boston MA, New Haven CT, Stony Brook NY, New York NY,

Sponsor: Greenwich LifeSciences, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05232916

Phase3, Recruiting

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

for

Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05389423

Phase1, Recruiting

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

for

Diffuse Large B Cell Lymphoma, Lymphoma, Non-Hodgkin

Location: Baltimore MD, Randallstown MD

Sponsor: The Alvin and Lois Lapidus Cancer Institute

Sex: All

Age: 18+

Code: NCT00333008

Phase2, Recruiting

Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

for

Hematologic Neoplasms

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 70+

Code: NCT05327023

Phase1, Phase2, Recruiting

Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias

for

Leukemia, Lymphocytic, Chronic, B-Cell,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06364423

Phase1, Phase2, Recruiting

CHIP/CCUS Natural History Protocol

for

Clonal Hematopoiesis of Indeterminate Potential,

Location: Bethesda MD

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 18 - 70+

Code: NCT04102423

Recruiting

Caregiving Networks Across Disease Context and the Life Course

for

Inherited Metabolic Disorders, Undiagnosed Diseases,

Location: Bethesda MD

Sponsor: National Human Genome Research Institute (NHGRI)

Sex: All

Age: 18 - 70+

Code: NCT05007990

Recruiting

Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)

for

Mild Cognitive Impairment, Alzheimer Disease, Memory Impairment

Location: Baltimore MD

Sponsor: Johns Hopkins University

Sex: All

Age: 55+

Code: NCT04601038

Phase2, Recruiting

CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

for

Solid Tumors, GI Cancer

Location: Boston MA, Baltimore MD, Washington DC, Durham NC,

Sponsor: Curegenix Inc.

Sex: All

Age: 18+

Code: NCT02675946

Phase1, Recruiting

Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis

for

Psoriasis

Location: Rockville MD

Sponsor: Washington Dermatology Center

Sex: All

Age: 18+

Code: NCT03453190

Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

for

High-Risk Non-Muscle-Invasive Bladder Cancer

Location: Halifax, Boston MA, The Bronx NY, New York NY,

Sponsor: CG Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06567743

Phase2, Recruiting

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

for

Lymphangioleiomyomatosis

Location: Bethesda MD

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: Female

Age: 18 - 70+

Code: NCT01799538

Phase1, Phase2, Recruiting

Efficacy of Extended-Release Liposomal Bupivacaine for Post-Operative Urogynecologic Surgery

for

Postoperative Pain

Location: Bethesda MD

Sponsor: Walter Reed National Military Medical Center

Sex: Female

Age: 18+

Code: NCT02287246

Recruiting

Lumbosacral Spinal Stenosis - Non-Invasive Postural Therapy for Older Adult Veterans

for

Lumbar Spinal Stenosis

Location: Baltimore MD

Sponsor: VA Office of Research and Development

Sex: All

Age: 55 - 70+

Code: NCT06089746

Recruiting

Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions

for

Dyslipidemia, Atherosclerosis

Location: Bethesda MD

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 10 - 70+

Code: NCT06676046

Recruiting

PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder

for

Alcohol Use Disorder

Location: Bethesda MD

Sponsor: National Institute of Mental Health (NIMH)

Sex: All

Age: 18 - 70

Code: NCT06795581

Phase1, Recruiting

Popular cities in Maryland

Annapolis Bethesda Baltimore Rockville

Paid Clinical Trials Maryland

Filter results

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene

Virtual Reality Therapy for Cancer-Treatment Associated Symptoms

Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Interested in new trials?

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias

CHIP/CCUS Natural History Protocol

Caregiving Networks Across Disease Context and the Life Course

Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)

CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

Efficacy of Extended-Release Liposomal Bupivacaine for Post-Operative Urogynecologic Surgery

Lumbosacral Spinal Stenosis - Non-Invasive Postural Therapy for Older Adult Veterans

Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions

PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder

Popular cities in Maryland